CJC 1295 with DAC

CJC-1295 with DAC is a cutting-edge peptide designed to mimic the body’s natural Growth Hormone Releasing Hormone (GHRH). This innovative compound is engineered to bind with specific receptors in the pituitary gland, potentially triggering a cascade of biological processes that enhance the secretion and circulation of growth hormones (GH) throughout the body. Preclinical studies have demonstrated that CJC-1295 DAC administration leads to a significant increase in growth hormone levels, making it a valuable tool for scientific research. One of the standout features of CJC1295 DAC is its extended half-life, which sets it apart from other peptides used in scientific research. This is achieved through its unique Drug Affinity Complex (DAC) technology, which enables the peptide to form stable bonds with albumin in the blood plasma. This bio-conjugation process significantly prolongs its presence in the body, allowing for sustained increases in growth hormone levels over an extended period. Unlike other peptides that degrade quickly, CJC-1295 DAC offers researchers a reliable option for long-term studies.